Ostrum Asset Management’s Pfizer PFE Stock Holding History

Ostrum Asset Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.49M	Sell	124,258 -10,249	-8%	-$273K	0.2%	73
2025 Q4	$3.35M	Sell	134,507 -30,678	-19%	-$774K	0.16%	94
2025 Q3	$4.21M	Buy	165,185 +8,076	+5%	+$199K	0.19%	87
2025 Q2	$3.81M	Buy	157,109 +25,373	+19%	+$592K	0.18%	100
2025 Q1	$3.34M	Sell	131,736 -69,652	-35%	-$1.82M	0.18%	105
2024 Q4	$5.34M	Buy	201,388 +34,354	+21%	+$932K	0.46%	37
2024 Q3	$4.83M	Sell	167,034 -1,230	-0.7%	-$35.9K	0.4%	50
2024 Q2	$4.71M	Sell	168,264 -66,513	-28%	-$1.83M	0.41%	48
2024 Q1	$6.52M	Sell	234,777 -22,478	-9%	-$624K	0.51%	26
2023 Q4	$7.41M	Buy	257,255 +85,681	+50%	+$2.59M	0.64%	17
2023 Q3	$5.69M	Sell	171,574 -40,693	-19%	-$1.44M	0.53%	27
2023 Q2	$7.79M	Sell	212,267 -2,685	-1%	-$105K	0.65%	14
2023 Q1	$8.77M	Buy	+214,952	New	+$9.28M	0.76%	9

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Ostrum Asset Management's PFE Position: Q1 2026 in Review

Ostrum Asset Management reduced its Pfizer (PFE) stake by 7.6% in Q1 2026, selling an estimated $273K and leaving 124,258 shares worth $3.49M. The position accounts for 0.2% of the portfolio, ranked #73.

Ostrum Asset Management first reported a position in PFE in Q1 2023 and has held it in 13 quarters since. The position peaked at $8.77M in Q1 2023. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

Ostrum Asset Management held 124,258 shares of Pfizer worth $3.49M as of Q1 2026.
Ostrum Asset Management sold 10,249 Pfizer shares in Q1 2026, an estimated $273K.
Pfizer made up 0.2% of Ostrum Asset Management's portfolio in Q1 2026, its #73 holding.
Ostrum Asset Management first reported a position in Pfizer in Q1 2023 and has held it in 13 quarters since.
Ostrum Asset Management's Pfizer position peaked at $8.77M in Q1 2023.
2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Ostrum Asset Management's 13F filing for Q1 2026, filed 14 May 2026.